Study to Assess Safety, Tolerability and PK of AZD1480 in Patients With Solid Tumours
This study is being conducted to assess the safety, tolerability and PK of AZD1480 in patients with advanced solid malignancies.
Solid Malignancies
DRUG: AZD1480
Safety and tolerability as assessed by Adverse events, vital signs, ECGs, Pulmonary Function Tests (DLco, FEV, FVC, Oxygen saturation) and laboratory data (chemistry, hematology and Urinalysis), Information will be collected from the time the informed consent is signed, throughout the study
Evaluation of the pharmacokinetics of AZD1480, During all cycles
This study is being conducted to assess the safety, tolerability and PK of AZD1480 in patients with advanced solid malignancies.